BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 677818)

  • 1. Effects of acetazolamide on myotonia.
    Griggs RC; Moxley RT; Riggs JE; Engel WK
    Ann Neurol; 1978 Jun; 3(6):531-7. PubMed ID: 677818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetazolamide-induced weakness in paramyotonia congenita.
    Riggs JE; Griggs RC; Moxley RT
    Ann Intern Med; 1977 Feb; 86(2):169-73. PubMed ID: 835937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.
    Ptáĉek LJ; Tawil R; Griggs RC; Meola G; McManis P; Barohn RJ; Mendell JR; Harris C; Spitzer R; Santiago F
    Neurology; 1994 Aug; 44(8):1500-3. PubMed ID: 8058156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acetazolamide on insulin sensitivity in myotonic disorders.
    Corbett A; Kingston W; Griggs RC; Moxley RT
    Arch Neurol; 1984 Jul; 41(7):740-3. PubMed ID: 6378152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of paramyotonia congenita with acetazolamide.
    Benstead TJ; Camfield PR; King DB
    Can J Neurol Sci; 1987 May; 14(2):156-8. PubMed ID: 3607618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetazolamide-responsive myotonia congenita.
    Trudell RG; Kaiser KK; Griggs RC
    Neurology; 1987 Mar; 37(3):488-91. PubMed ID: 3822145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acetazolamide on myotonia.
    Griggs RC; Moxley RT; Riggs JE; Engel WK
    Trans Am Neurol Assoc; 1977; 102():133-5. PubMed ID: 356394
    [No Abstract]   [Full Text] [Related]  

  • 8. Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients.
    Streib EW
    Muscle Nerve; 1987 Feb; 10(2):155-62. PubMed ID: 3102961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypokalemic paralysis in two patients with paramyotonia congenita (PC) and known hyperkalemic/exercise-induced weakness.
    Streib EW
    Muscle Nerve; 1989 Nov; 12(11):936-7. PubMed ID: 2608088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of paramyotonia congenita with and without myotonia in a warm environment.
    Haass A; Ricker K; Rüdel R; Lehmann-Horn F; Böhlen R; Dengler R; Mertens HG
    Muscle Nerve; 1981; 4(5):388-95. PubMed ID: 6793868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene.
    Ebers GC; George AL; Barchi RL; Ting-Passador SS; Kallen RG; Lathrop GM; Beckmann JS; Hahn AF; Brown WF; Campbell RD
    Ann Neurol; 1991 Dec; 30(6):810-6. PubMed ID: 1686388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paramyotonia congenita without cold paralysis: a case report.
    Izumi Y; Fukuuchi Y; Koto A; Nakajima S
    Keio J Med; 1994 Jun; 43(2):94-7. PubMed ID: 8089960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myotonic disorders and the periodic paralyses.
    Griggs RC
    Adv Neurol; 1977; 17():143-59. PubMed ID: 888733
    [No Abstract]   [Full Text] [Related]  

  • 14. On the beneficial action of acetazolamide in hypokalemic periodic paralysis: study of the carbohydrate metabolism.
    Viskoper RJ; Fidel J; Horn T; Tzivoni D; Chaco J
    Am J Med Sci; 1973 Aug; 266(2):124-9. PubMed ID: 4742366
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders.
    Tawil R; Moxley RT; Griggs RC
    Neurology; 1993 Jun; 43(6):1105-6. PubMed ID: 8170551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis.
    Ricker K; Böhlen R; Rohkamm R
    Neurology; 1983 Dec; 33(12):1615-8. PubMed ID: 6417558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of potassium-sensitive periodic paralysis with cardiac dysrhythmia].
    Nakamagoe K; Fujita T; Ohkoshi N; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1997 Mar; 37(3):239-42. PubMed ID: 9217424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family.
    de Silva SM; Kuncl RW; Griffin JW; Cornblath DR; Chavoustie S
    Muscle Nerve; 1990 Jan; 13(1):21-6. PubMed ID: 2325698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Periodic familial paralysis with hypokalemia. Hemodynamic and metabolic studies: favourable effect of acetazolamide (author's transl)].
    Goulon M; Raphael JC; Simon N
    Rev Neurol (Paris); 1978 Nov; 134(11):655-72. PubMed ID: 751160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.
    Ptacek LJ; Gouw L; Kwieciński H; McManis P; Mendell JR; Barohn RJ; George AL; Barchi RL; Robertson M; Leppert MF
    Ann Neurol; 1993 Mar; 33(3):300-7. PubMed ID: 8388676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.